机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China School of Basic Medical Sciences & Forensic Medicine, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu 610041, China.四川大学华西医院[2]Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.[3]School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.[4]Department of Radiotherapy, The First Affiliated Hospital of Hainan Medical University, Haikou 571199, China.[5]Department of Otorhinolaryngology and Head and Neck Surgery, The Affiliated Lihuili Hospital, Ningbo University, Ningbo 315211, China.
Polyphenols and their derivates, a kind of natural product distributed in herb plants, vegetables, and fruits, are the most abundant antioxidants in the human diet and have been found to display cancer-preventative effects in several epidemiological studies. The scientific community has also validated the anti-cancer bioactivities and low toxicities of polyphenolic compounds, including flavones, tannins, phenolic acids, and anthocyanins, through in vitro and in vivo studies. However, the low stability, weak targeting ability, poor solubility, and low bioavailability of pure polyphenolic agents have significantly impaired their treatment efficacy. Nowadays, nano-based technology has been applied to surmount these restrictions and maximize the treatment efficacy of polyphenols. In this review, we summarize the advantages and related mechanisms of polyphenols in cancer treatment. Moreover, aiming at the poor solubility and low bioavailability of pure polyphenols in vivo, the advantages of nano-based delivery systems and recent research developments are highlighted. Herein, particular emphasis is mainly placed on the most widely used nanomaterials in the delivery of natural products, including liposomes, micelles, and nanogels. Finally, we present an overview and the challenges of future implementations of nano-based delivery systems of polyphenolic compounds in the cancer therapeutic field.
基金:
National Natural Science Foundation of China, grant number
8226100505, the Ningbo Clinical Research Center for Otolaryngology Head and Neck Disease, grant
number 2022L005, and the Ningbo Medical and Health Brand Discipline, grant number PPXK2018-02,
Ningbo “Technology Innovation 2025” Major Special Project, grant number 2020Z097.
第一作者机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China School of Basic Medical Sciences & Forensic Medicine, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu 610041, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Jia Wenhui,Zhou Li,Li Lei,et al.Nano-Based Drug Delivery of Polyphenolic Compounds for Cancer Treatment: Progress, Opportunities, and Challenges[J].PHARMACEUTICALS.2023,16(1):doi:10.3390/ph16010101.
APA:
Jia Wenhui,Zhou Li,Li Lei,Zhou Ping&Shen Zhisen.(2023).Nano-Based Drug Delivery of Polyphenolic Compounds for Cancer Treatment: Progress, Opportunities, and Challenges.PHARMACEUTICALS,16,(1)
MLA:
Jia Wenhui,et al."Nano-Based Drug Delivery of Polyphenolic Compounds for Cancer Treatment: Progress, Opportunities, and Challenges".PHARMACEUTICALS 16..1(2023)